Trekhealth Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 3111.19%
- Profit Growth 2358.64%
- Ebitda 2358.64%
- Net Worth 57.56%
- Total Assets 257.79%
About Trekhealth Pharma
Trekhealth Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 2018 (Six years and two months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Navin Atal and Ruchita Atal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2018PTC342397
- Company No.
342397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Trekhealth Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navin Atal  | Director | 29-Nov-2018 | Current |
| Ruchita Atal | Director | 29-Nov-2018 | Current |
Financial Performance of Trekhealth Pharma.
Trekhealth Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 3111.19% increase. The company also saw a substantial improvement in profitability, with a 2358.64% increase in profit. The company's net worth Soared by an impressive increase of 57.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trekhealth Pharma?
Unlock access to Trekhealth Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chand Kumar Atal FoundationNavin Atal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trekhealth Pharma?
Unlock and access historical data on people associated with Trekhealth Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trekhealth Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trekhealth Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.